Biomarkers for predicting type 2 diabetes development—Can metabolomics improve on existing biomarkers?-Reference-Cited by-同舟云学术

Biomarkers for predicting type 2 diabetes development—Can metabolomics improve on existing biomarkers?

Published:2017-07-10 Issue:7 Volume:12 Page:e0177738
ISSN:1932-6203
Container-title:PLOS ONE
language:en
Short-container-title:PLoS ONE

Author:

Savolainen Otto,Fagerberg Björn,Vendelbo Lind Mads,Sandberg Ann-Sofie,Ross Alastair B.,Bergström Göran

Funder

Hjärt-Lungfonden

Västra Götalandsregionen

Chalmers area of advance life science engineering

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference34 articles.

1. Diabetes Mellitus and its Chronic Complications;BK Bailes;AORN Journal,2002

2. Adiponectin in relation to insulin sensitivity and insulin secretion in the development of type 2 diabetes: a prospective study in 64-year-old women;B Fagerberg;Journal of internal medicine,2011

3. Adiponectin Levels and Risk of Type 2 Diabetes: A Systematic Review and Meta-analysis;S Li;JAMA,2009

4. The use of mass spectrometry for analysing metabolite biomarkers in epidemiology: methodological and statistical considerations for application to large numbers of biological samples;MV Lind;Eur J Epidemiol,2016

5. The potential of novel biomarkers to improve risk prediction of type 2 diabetes;C Herder;Diabetologia,2014

Cited by 36 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Long-term physical inactivity induces significant changes in biochemical pathways related to metabolism of proteins and glycerophospholipids in mice;Molecular Omics;2024

2. Artesunate improves glucose and lipid metabolism in db/db mice by regulating the metabolic profile and the MAPK/PI3K/Akt signalling pathway;Phytomedicine;2024-01

3. Metabolomics approach in pharmacognosy;Pharmacognosy;2024

4. Toward Systems-Level Metabolic Analysis in Endocrine Disorders and Cancer;Endocrinology and Metabolism;2023-12-31

5. Profile of plasma free amino acids, carnitine and acylcarnitines, and JAK2^v617f mutation as potential metabolic markers in children with type 1 diabetic nephropathy;Biomedical Chromatography;2023-09-20